» Articles » PMID: 39028621

PARP1-driven Repair of Topoisomerase IIIα DNA-protein Crosslinks by FEN1

Overview
Journal Cell Rep
Publisher Cell Press
Date 2024 Jul 19
PMID 39028621
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent DNA-protein crosslinks formed by human topoisomerase IIIα (TOP3A-DPCs) interfere with DNA metabolism and lead to genome damage and cell death. Recently, we demonstrated that such abortive TOP3A-DPCs are ubiquitylated and proteolyzed by Spartan (SPRTN). Here, we identify transient poly(ADP-ribosylation) (PARylation) in addition to ubiquitylation as a signaling mechanism for TOP3A-DPC repair and provide evidence that poly(ADP-ribose) polymerase 1 (PARP1) drives the repair of TOP3A-DPCs by recruiting flap endonuclease 1 (FEN1) to the TOP3A-DPCs. We find that blocking PARylation attenuates the interaction of FEN1 and TOP3A and that TOP3A-DPCs accumulate in cells with compromised PARP1 activity and in FEN1-deficient cells. We also show that PARP1 suppresses TOP3A-DPC ubiquitylation and that inhibiting the ubiquitin-activating enzyme E1 (UBE1) increases TOP3A-DPCs, consistent with ubiquitylation serving as a signaling mechanism for TOP3A-DPC repair mediated by SPRTN and TDP2. We propose that two concerted pathways repair TOP3A-DPCs: PARylation-driven FEN1 excision and ubiquitylation-driven SPRTN-TDP2 excision.

References
1.
Pommier Y, Nussenzweig A, Takeda S, Austin C . Human topoisomerases and their roles in genome stability and organization. Nat Rev Mol Cell Biol. 2022; 23(6):407-427. PMC: 8883456. DOI: 10.1038/s41580-022-00452-3. View

2.
Gautam A, Fawcett H, Burdova K, Brazina J, Caldecott K . APE1-dependent base excision repair of DNA photodimers in human cells. Mol Cell. 2023; 83(20):3669-3678.e7. DOI: 10.1016/j.molcel.2023.09.013. View

3.
Nitiss J . Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009; 9(5):338-50. PMC: 2748742. DOI: 10.1038/nrc2607. View

4.
Ray Chaudhuri A, Nussenzweig A . The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017; 18(10):610-621. PMC: 6591728. DOI: 10.1038/nrm.2017.53. View

5.
Yang F, Hu Z, Guo Z . Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy. Biomolecules. 2022; 12(7). PMC: 9312813. DOI: 10.3390/biom12071007. View